There are currently 301 active clinical trials seeking participants for Cancer research studies. The states with the highest number of trials for Cancer participants are California, Texas, New York and Florida.
Care Coordination Educational Intervention Study for Patients From Rural Areas With Early Stage Cancer
NCT05723250
Recruiting
Care Coordination is an essential component of cancer care delivery. Many patients experience poor care coordination. In this study, we hypothesize that provision of a video educational intervention to teach patients about cancer, care coordination and self-advocacy will improve patients' perception of care coordination. Cancer patients with early stage disease scheduled to receive adjuvant therapy, and who reside in a rural area, will be enrolled onto the study. Patients will be randomized to r... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/08/2023
Locations: University of Vermont Cancer Center, Burlington, Vermont
Conditions: Cancer
Register for Updates
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
NCT03383094
Recruiting
The purpose of this study is to compare any good or bad effects of using pembrolizumab (an experimental drug) and radiation therapy (RT), compared to using cisplatin chemotherapy and radiation therapy (RT) in the treatment of patients with head and neck squamous cell carcinoma (HNSCC).
Gender:
All
Ages:
18 years and above
Trial Updated:
05/01/2023
Locations: University of Arizona Cancer Center, Tucson, Arizona +6 locations
Conditions: Head and Neck Squamous Cell Carcinoma, Cancer, Cancer of Head and Neck, Cancer, Advanced, Cancer, Metastatic, Tumor, Tumor Recurrence, Tumor Neck, Tumor Metastasis, Oral Cancer, Oropharyngeal Cancer, Oropharynx Cancer, Oropharynx Cancer, Stage III, Oropharynx Cancer, Recurrent, Oropharynx Cancer, Metastatic
Register for Updates
EMPOWER 3: Improving Palliative Care Health Literacy and Utilization
NCT04733469
Recruiting
Through this award, Michael Hoerger, PhD, MSCR, a psychologist at the Tulane Cancer Center in Louisiana, will lead a study called EMPOWER 3 designed to test an educational intervention to help patients understand palliative care, use it, and feel better emotionally and physically. Participants will be adults with serious cancer diagnoses. Participants will be randomized into two groups. Patients in the control group will get enhanced usual care, meaning standard cancer care and several additiona... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/27/2023
Locations: University Medical Center, New Orleans, Louisiana +1 locations
Conditions: Cancer, Neoplasm Malignant
Register for Updates
Comprehensive Tobacco Cessation for Cancer Patients and Survivors
NCT05805722
Recruiting
The purpose of this research study is to learn how best to incorporate tobacco cessation treatment into clinical care for cancer patients, survivors, and caregivers.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/25/2023
Locations: Virginia Commonwealth University, Richmond, Virginia
Conditions: Tobacco Use Cessation, Cancer
Register for Updates
Multi-Cancer Early Detection (MCED) of Firefighters
NCT05780957
Recruiting
This study is an an observational prospective cohort research study to explore the performance of new blood and urine tests for the early detection of cancer among firefighters.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/24/2023
Locations: Vincere Cancer Center, Scottsdale, Arizona
Conditions: Cancer
Register for Updates
KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models
NCT05338073
Recruiting
This study will assess the ability of the Known Medicine platform to predict the efficacy of certain cancer drug treatments and to validate that tumor organoid drug sensitivity is representative of patient treatment outcomes.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/21/2023
Locations: Mayo Clinic, Rochester, Minnesota +2 locations
Conditions: Cancer, Predictive Cancer Model, Effects of Chemotherapy
Register for Updates
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
NCT01542879
Recruiting
A research study on the diagnosis of spread of disease for children who have been diagnosed with solid tumors using a new whole body imaging technique and a new MR contrast agent (ferumoxytol). Standard tests that are used to determine the extent and possible spread of a child's disease include magnetic resonance (MR) imaging, computed tomography (CT), Positron Emission Tomography (PET) as well as bone scanning, and metaiodobenzylguanidine (MIBG) scanning. The purpose of this study is to determi... Read More
Gender:
All
Ages:
Between 6 years and 40 years
Trial Updated:
04/03/2023
Locations: Stanford University Cancer Institute, Stanford, California
Conditions: Cancer
Register for Updates
Body Composition Post Cancer Treatment
NCT03690401
Recruiting
The purpose of this study is to assess how bone density and body composition changes after a cancer patient completes treatment and through 12-weeks post-treatment. Patients who enroll in the 12-week exercise program, Moving On, and those that do not elect to participate in the Moving On program will both be tracked, with assessments including SOZO measurements, DEXA scan (bone density and whole body composition), performance status tests, food log, urine color test, and other study assessments.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/29/2023
Locations: Prisma Health Cancer Institute Center for Integrative Oncology and Survivorship, Greenville, South Carolina
Conditions: Cancer
Register for Updates
Body Composition During Cancer Treatment
NCT03784911
Recruiting
The purpose of this study is to assess how bone density and body composition changes over a cancer patient's treatment via SOZO measurements, DEXA scan (bone density and whole body composition), performance status tests, food log, urine color test, and other study assessments. These assessments will begin after cancer diagnosis but prior to intervention, and continue during treatment and at post-treatment visits.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/29/2023
Locations: Prisma Health Cancer Institute Center for Integrative Oncology and Survivorship, Greenville, South Carolina
Conditions: Cancer
Register for Updates
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
NCT03061305
Recruiting
Many patients are treated for advanced cancer without knowledge of underlying molecular features that might indicate FDA approved therapies or potential eligibility for biomarker-selected clinical trials. The Strata Trial (STR-001-001) has been initiated by Strata Oncology to evaluate the clinical benefit of systematic comprehensive genomic profiling for participants with advanced cancer using real-world data and endpoints, while assessing the proportion of participants available for clinical t... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
02/23/2023
Locations: University of Alabama, Birmingham, Birmingham, Alabama +39 locations
Conditions: Cancer, Adult Solid Tumor, Lymphoma, Multiple Myeloma
Register for Updates
Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health
NCT05746169
Recruiting
The DREAM Cohort is a longitudinal observational study developed to enhance our understanding of how multiple exposures to environmental chemicals and pollutants across a diverse population of pregnant women and their offspring are linked to cancer risks. Because pregnancy induces multiple maternal hormonal and physiological changes that can increase cancer susceptibility to environmental chemical exposures, this study will focus on pregnancy as a period of particular vulnerability to toxic agen... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
02/17/2023
Locations: Fresno Community Regional Medical Center, Fresno, California +1 locations
Conditions: Cancer
Register for Updates
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
NCT04106492
Recruiting
The purpose of this study is to evaluate the safety, tolerability, and preliminary activity of SQ3370 in patients with advanced solid tumors.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/08/2023
Locations: City of Hope, Duarte, California +9 locations
Conditions: Cancer
Register for Updates